BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30691592)

  • 1. Recipient obesity does not affect survival after deceased donor liver transplantation for hepatocellular carcinoma. A national retrospective cohort study in the United States.
    Ata N; Ayloo S; Tsung A; Molinari M
    HPB (Oxford); 2019 Jan; 21(1):67-76. PubMed ID: 30691592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
    Salgia RJ; Goodrich NP; Marrero JA; Volk ML
    Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China.
    Chen J; Yang Z; Gao F; Zhou Z; Chen J; Lu D; Wang K; Sui M; Wang Z; Guo W; Lyu G; Qi H; Cai J; Yang J; Zheng S; Xu X
    Cancer Biol Med; 2024 Feb; 21(4):347-62. PubMed ID: 38425217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
    Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
    Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
    Khorsandi SE; Yip VS; Cortes M; Jassem W; Quaglia A; O'Grady J; Heneghan M; Aluvihare V; Agarwal K; Menon K; Vilca-Melendez H; Prachalias A; Srinivasan P; Suddle A; Rela M; Heaton N
    Transplantation; 2016 Sep; 100(9):1916-24. PubMed ID: 26982954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
    Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
    Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts.
    Croome KP; Wall W; Chandok N; Beck G; Marotta P; Hernandez-Alejandro R
    Liver Transpl; 2013 Nov; 19(11):1214-23. PubMed ID: 23907778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
    Rich N; Tanriover B; Singal AG; Marrero JA
    Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK.
    Wallace D; Cowling TE; Walker K; Suddle A; Rowe I; Callaghan C; Gimson A; Bernal W; Heaton N; van der Meulen J
    Br J Surg; 2020 Jun; 107(7):896-905. PubMed ID: 32128793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Silva JP; Maurina MN; Tsai S; Christians KK; Clarke CN; Mogal H; Saeian K; Gamblin TC
    J Am Coll Surg; 2019 Mar; 228(3):245-254. PubMed ID: 30639515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
    Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
    Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant.
    Adams LA; Arauz O; Angus PW; Sinclair M; MacDonald GA; Chelvaratnam U; Wigg AJ; Yeap S; Shackel N; Lin L; Raftopoulos S; McCaughan GW; Jeffrey GP;
    J Gastroenterol Hepatol; 2016 May; 31(5):1016-24. PubMed ID: 26589875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
    Chan SC
    Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.